• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过血浆中的炎症标志物对实体器官移植受者的巨细胞病毒病进行特征描述。

Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma.

机构信息

Department of Microbiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.

出版信息

PLoS One. 2013 Apr 8;8(4):e60767. doi: 10.1371/journal.pone.0060767. Print 2013.

DOI:10.1371/journal.pone.0060767
PMID:23593305
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3620537/
Abstract

BACKGROUND

While several studies have examined the general inflammatory responses in relation to cytomegalovirus infection, the identification of the various inflammatory mediators as well as their relative importance is far from clear.

PATIENTS AND METHODS

Solid organ recipients enrolled in an international multicenter trial of cytomegalovirus disease treatment (the VICTOR study) were analyzed (n = 289) (ClinicalTrials.gov NCT00431353). Plasma markers of inflammation and endothelial cell activation were assessed at baseline by enzyme immunoassays.

RESULTS

The major findings were: (i) Plasma levels of the CXC-chemokine interferon-inducible protein-10 (P<0.001) and C-reactive protein (P = 0.046) were independently associated with the presence of cytomegalovirus DNAemia above lower level of quantification. (ii) High levels of CC-chemokine ligand 21 (P = 0.027) and pentraxin 3 (P = 0.033) were independently associated with tissue invasive cytomegalovirus disease as opposed to cytomegalovirus syndrome.

CONCLUSION

Our findings illustrate the complex interaction between cytomegalovirus and the immune system, involving a wide range of inflammatory mediators that could be associated to disease manifestations in cytomegalovirus related disease.

摘要

背景

虽然已有多项研究探讨了巨细胞病毒感染相关的一般炎症反应,但各种炎症介质的鉴定及其相对重要性仍远未明确。

患者和方法

我们对参加巨细胞病毒病治疗国际多中心试验(VICTOR 研究)的实体器官受者进行了分析(n=289)(ClinicalTrials.gov NCT00431353)。采用酶联免疫吸附法在基线时评估炎症和血管内皮细胞激活的血浆标志物。

结果

主要发现包括:(i)血浆中趋化因子干扰素诱导蛋白-10(P<0.001)和 C 反应蛋白(P=0.046)的水平与定量下限以上的巨细胞病毒 DNA 血症的存在独立相关。(ii)CC 趋化因子配体 21(P=0.027)和五聚素 3(P=0.033)的高水平与组织侵袭性巨细胞病毒病而不是巨细胞病毒综合征独立相关。

结论

我们的研究结果表明巨细胞病毒与免疫系统之间存在复杂的相互作用,涉及多种炎症介质,这些介质可能与巨细胞病毒相关疾病的临床表现相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f028/3620537/ab42834a1eda/pone.0060767.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f028/3620537/1b2e25848259/pone.0060767.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f028/3620537/ab42834a1eda/pone.0060767.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f028/3620537/1b2e25848259/pone.0060767.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f028/3620537/ab42834a1eda/pone.0060767.g002.jpg

相似文献

1
Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma.通过血浆中的炎症标志物对实体器官移植受者的巨细胞病毒病进行特征描述。
PLoS One. 2013 Apr 8;8(4):e60767. doi: 10.1371/journal.pone.0060767. Print 2013.
2
Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcome.实体器官移植受者巨细胞病毒病的治疗:炎症标志物作为结局预测因子。
Transplantation. 2012 Nov 27;94(10):1060-5. doi: 10.1097/TP.0b013e31826c39de.
3
Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients.骨保护素升高预示实体器官移植受者抗巨细胞病毒治疗期间病毒学结局不佳。
Transplantation. 2015 Jan;99(1):100-5. doi: 10.1097/TP.0000000000000227.
4
Pre-transplant assessment of CMV-specific immune response by Elispot assay in kidney transplant recipients.肾移植受者中通过酶联免疫斑点试验进行巨细胞病毒特异性免疫反应的移植前评估。
New Microbiol. 2015 Jul;38(3):329-35. Epub 2015 Jul 6.
5
Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.血浆中炎症生物标志物的动力学可预测异基因造血干细胞移植受者巨细胞病毒 DNA 血症发作的发生和特征。
Med Microbiol Immunol. 2019 Aug;208(3-4):405-414. doi: 10.1007/s00430-019-00594-w. Epub 2019 Mar 25.
6
Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.普通非免疫抑制重症监护病房人群中的巨细胞病毒再激活:发病率、危险因素、与器官功能障碍的关联及炎症生物标志物
J Crit Care. 2015 Apr;30(2):276-81. doi: 10.1016/j.jcrc.2014.10.002. Epub 2014 Oct 8.
7
Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR Trial.从口服缬更昔洛韦与更昔洛韦静脉治疗实体器官移植受者巨细胞病毒病的随机研究中吸取的经验教训:VICTOR 试验。
Clin Infect Dis. 2016 May 1;62(9):1154-60. doi: 10.1093/cid/ciw084. Epub 2016 Feb 16.
8
The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients.巨细胞病毒 ELISPOT 检测在预测造血细胞移植受者低水平 CMV 再激活结局中的作用。
J Infect Dis. 2019 Feb 23;219(6):898-907. doi: 10.1093/infdis/jiy592.
9
Impact of cytomegalovirus on early immunosenescence of CD8+ T lymphocytes after solid organ transplantation.巨细胞病毒对实体器官移植后 CD8+ T 淋巴细胞早期免疫衰老的影响。
J Gerontol A Biol Sci Med Sci. 2013 Jan;68(1):1-5. doi: 10.1093/gerona/gls130. Epub 2012 May 2.
10
Intrapulmonary Human Cytomegalovirus Replication in Lung Transplant Recipients Is Associated With a Rise of CCL-18 and CCL-20 Chemokine Levels.肺移植受者肺内人巨细胞病毒复制与CCL-18和CCL-20趋化因子水平升高有关。
Transplantation. 2017 Jan;101(1):197-203. doi: 10.1097/TP.0000000000001065.

引用本文的文献

1
Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.血浆中炎症生物标志物的动力学可预测异基因造血干细胞移植受者巨细胞病毒 DNA 血症发作的发生和特征。
Med Microbiol Immunol. 2019 Aug;208(3-4):405-414. doi: 10.1007/s00430-019-00594-w. Epub 2019 Mar 25.
2
Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conorii infection.在临床和实验性恙虫病东方体感染中,稳态趋化因子 CCL19 和 CCL21 的表达增加。
BMC Infect Dis. 2014 Feb 9;14:70. doi: 10.1186/1471-2334-14-70.

本文引用的文献

1
Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcome.实体器官移植受者巨细胞病毒病的治疗:炎症标志物作为结局预测因子。
Transplantation. 2012 Nov 27;94(10):1060-5. doi: 10.1097/TP.0b013e31826c39de.
2
Characterization of CCL19 and CCL21 in rheumatoid arthritis.类风湿关节炎中CCL19和CCL21的特征分析
Arthritis Rheum. 2011 Apr;63(4):914-22. doi: 10.1002/art.30232.
3
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.
慢性丙型肝炎病毒感染者体内存在趋化因子 CXCL10 的拮抗剂形式。
J Clin Invest. 2011 Jan;121(1):308-17. doi: 10.1172/JCI40594. Epub 2010 Dec 22.
4
Pentraxins in innate immunity: lessons from PTX3.先天免疫中的五聚素:PTX3 的启示。
Cell Tissue Res. 2011 Jan;343(1):237-49. doi: 10.1007/s00441-010-1018-0. Epub 2010 Aug 4.
5
Detection of respiratory viruses and the associated chemokine responses in serious acute respiratory illness.严重急性呼吸道疾病中呼吸道病毒的检测及相关趋化因子反应。
Thorax. 2010 Jul;65(7):639-44. doi: 10.1136/thx.2009.132480.
6
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.国际实体器官移植中巨细胞病毒管理共识指南。
Transplantation. 2010 Apr 15;89(7):779-95. doi: 10.1097/TP.0b013e3181cee42f.
7
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.巨细胞病毒糖蛋白B基因多态性对患有巨细胞病毒病的实体器官移植受者预后的影响。
Clin Infect Dis. 2009 Oct 15;49(8):1160-6. doi: 10.1086/605633.
8
Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease.外源性五聚素3可恢复小鼠慢性肉芽肿病的抗真菌耐药性并抑制炎症。
J Immunol. 2009 Oct 1;183(7):4609-18. doi: 10.4049/jimmunol.0900345. Epub 2009 Sep 4.
9
Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients.在实体器官移植受者中,缬更昔洛韦与静脉注射更昔洛韦治疗巨细胞病毒疾病的长期结果。
Am J Transplant. 2009 May;9(5):1205-13. doi: 10.1111/j.1600-6143.2009.02617.x.
10
An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomes.巨细胞病毒病患者中疱疹病毒合并感染的评估:与临床和病毒学结果的相关性
Am J Transplant. 2009 Feb;9(2):374-81. doi: 10.1111/j.1600-6143.2008.02501.x. Epub 2008 Dec 15.